Answer
Combining NovoSeven (eptacog alfa) with recombinant factor XIII is not recommended based on a non-clinical study, and no clinical interaction data are available.
Sources for this answer
- NovoSeven 2mg (100 KIU) powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked